These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7426922

  • 1. Misonidazole in fractionated radiotherapy: are many small fractions best?
    Denekamp J, McNally NJ, Fowler JF, Joiner MC.
    Br J Radiol; 1980 Oct; 53(634):981-90. PubMed ID: 7426922
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD.
    Cancer Clin Trials; 1980 Oct; 3(2):179-86. PubMed ID: 6253098
    [Abstract] [Full Text] [Related]

  • 3. The effect of misonidazole in combination with radiation dose fractionation.
    Hill RP, Bush RS.
    Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
    [Abstract] [Full Text] [Related]

  • 4. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV.
    Cancer Clin Trials; 1980 Jun; 3(3):275-80. PubMed ID: 7438324
    [Abstract] [Full Text] [Related]

  • 5. Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: experimental and clinical results.
    Arcangeli G, Barocas A, Mauro F, Nervi C, Spanò M, Tabocchini A.
    Cancer; 1980 Jun 01; 45(11):2707-11. PubMed ID: 7379004
    [Abstract] [Full Text] [Related]

  • 6. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
    Dische S, Saunders MI, Flockhart IR.
    Br J Cancer Suppl; 1978 Jun 01; 3():318-21. PubMed ID: 209811
    [Abstract] [Full Text] [Related]

  • 7. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul 01; 57(679):585-95. PubMed ID: 6329395
    [Abstract] [Full Text] [Related]

  • 8. The effect of a hypoxic cell sensitizer on cancer radiotherapy: an analysis by a model.
    Okumura Y, Okajima S.
    Strahlentherapie; 1984 Oct 01; 160(10):620-3. PubMed ID: 6495356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H, Watarai J, Hoshino T.
    Gan To Kagaku Ryoho; 1984 Jun 01; 11(6):1225-30. PubMed ID: 6732250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of combined misonidazole and accelerated neon ions on a human melanoma transplanted into nude mice.
    Guichard M, Tenforde T, Curtis S, Malaise EP.
    Radiology; 1982 Jan 01; 142(1):219-23. PubMed ID: 6796997
    [Abstract] [Full Text] [Related]

  • 20. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
    Rofstad EK, Brustad T.
    Acta Radiol Oncol; 1981 Jan 01; 20(4):261-5. PubMed ID: 6277155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.